Embecta (EMBC) news
Recent news
Moody's Ratings changes Accelya's outlook to negative; affirms B3 CFR
Moody's Ratings has revised the outlook for Accelya to negative while affirming its Corporate Family Rating (CFR) at B3 . This decision reflects concerns about the company's financial stability and its ability to manage risks amid evolving market conditions. The negative outlook indicates that…
AInvest Wire · 6d agoEmbecta Q3 adjusted EPS USD 0.56 vs. IBES estimate USD 0.27
AInvest Wire · Aug 7, 2026EmbecTA outlook FY revenue USD 1,015-1,035 million
AInvest Wire · Aug 7, 2026Midera Food will replace Redwood Trust on S&P SmallCap 600
S&P Dow Jones Indices will implement changes to the S&P SmallCap 600 index ahead of the open of trading on Monday, June 22, 2026, as part of its quarterly rebalancing process. These adjustments aim to ensure the index remains representative of the small-cap market segment. Among the changes, Midera…
AInvest Wire · Jul 2, 2026EmbecTA closes purchase of Owen Mumford Holdings Limited
EmbecTA Corp. (Nasdaq: EMBC) has completed its acquisition of Owen Mumford Holdings Limited, a UK-based innovator in medical device and drug-delivery technologies, in a transaction valued at up to £150 million. The deal, which was announced in March 2026, includes an upfront cash payment of £100…
AInvest Wire · May 15, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.